"The journal selection process was straightforward, aligning well with our research focus." -Minah Kim, Cancer Research Author See more of what our authors are saying about publishing with the Journals. buff.ly/7x8ra8e

The Immuno-oncology collection highlights recent advances in immuno-oncology, including identification of biomarkers of response to immunotherapies, neoantigen vaccine development, antibody therapies, and cellular therapies. Check it out: buff.ly/L4GpWAx

Read the related article in Clinical Cancer Research, "SJPedPanel: A Pan-Cancer Gene Panel for Childhood Malignancies to Enhance Cancer Monitoring and Early Detection." doi.org/10.1158/1078...

Nominations for the 2026 Early Career Awards are open for Cancer Discovery, Cancer Research, and Clinical Cancer Research! View criteria and be the first to submit a nomination: buff.ly/Vhxuyt5

Read the new article just published in Blood Cancer Discovery: Tandem duplications in UBTF create XPO1-dependent nuclear export signals that reveal a leukemic therapeutic dependency doi.org/10.1158/2643...

#ICYMI Nominations for the 2026 Clinical Cancer Research Early Career Award will open next week.

When you submit to an AACR Journal, you'll benefit from rapid decision and publication times. Learn more about the Manuscript Turnaround Guarantee for Active AACR Members: buff.ly/KP7I5Z6

📅 Next week! Nominations will open for the 2025 Cancer Research Early Career Award. Stay tuned!

Not only do AACR Members receive a 10% discount on publishing fees, but some AACR scientific working groups offer additional discounts on top of this. Learn more: buff.ly/12PgSmX

Cancer Discovery News: Highlighting Must-Read Industry News. buff.ly/hNe0xKN

Nominations will open soon for the 2026 Cancer Discovery Early Career Award. Stay tuned for details.

Cancer Research Executive Editor Harmony Turk, PhD, will be at the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics. If you have a question about the journal or are interested in discussing your research, reach out to her at [email protected]. #Targets25

Ines Pulido presents her poster at #Targets25 and is pictured here with corresponding author Takeshi Shimamura and Associate Editor Danielle Large. Read the article published simultaneously: Heterobifunctional KRASG12D-HSP90 Inhibitors buff.ly/XRF1cAw

Attending #Targets25? Read this collection of articles that features recent research and review articles highlighting key advances in PROTAC and molecular glue development buff.ly/xdWDulw

Explore the Cancer Health Disparities article collection featured in the #AACRBlog post: aacrjournals.org/collection/1...

Cancer Discovery Senior Executive Editor Robert Kruger, PhD, will be at the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics. If you have a question about the journal or want to discuss your research, please reach out to him at [email protected]. #Targets25

Cancer Research Communications Associate Editor Emily Frieben, PhD, will be at the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics. If you have a question about the journal or want to discuss your research, reach out to her at [email protected]. #Targets25

Curious about opportunities to publish in AACR Journals? Visit AACR booth #101 at #Targets25 on October 24 at 1PM to chat with in-house editors Emily Frieben, PhD, and Danielle Large, PhD, about your research and publishing opportunities.

The Developmental Therapeutics collection highlights the discovery and validation of therapeutics currently in preclinical to early clinical development. Check out the included articles:

Molecular Cancer Therapeutics Associate Editor Danielle Large, PhD, will be at the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics. If you have a question about the journal or want to discuss your research, reach out to her at [email protected]. #Targets25

A team led by Dr. Benjamin Lok has found a new target to enhance radiation therapy in small cell lung cancer. By removing the function of gene HDAC3, cancer cells became more sensitive to radiation and tumour growth was inhibited: aacrjournals.org/mct/article/...; www.uhnresearch.ca/news/increas...

Molecular Cancer Therapeutics is the central hub for #FirstDisclosures of novel cancer therapeutics. Catch up on the latest articles: buff.ly/4JBMh5y

The Cancer Prevention & Early Detection collection showcases the latest innovations in early detection strategies, including topics such as non-invasive assays, advanced biomarker discovery, and the application of machine learning. Read the articles: buff.ly/tV2teMH

Read this collection of impactful Blood Cancer Discovery articles that highlight advanced lymphoma research by leveraging novel tools and techniques, uncovering molecular networks that drive oncogenesis and progression, and bringing innovative therapies to patients. buff.ly/q3NmZc2

Read the Cancer Discovery Piece: Rethinking Cancer Drug Development through Tumor-Agnostic Precision Medicine by @viveksubbiah.bsky.social doi.org/10.1158/2159...

Attending #ESMO25? Read this collection of articles from Clinical Cancer Research: buff.ly/WAcA0eg

Cancer Discovery Senior Editor I-Mei Siu, PhD, is attending #ESMO25. If you have a question about the journal or are interested in discussing your research, please reach out to her at [email protected].

If you’re interested in @aacrjournals.bsky.social Cancer Discovery, come say hello to me at #ESMO25!

"AACR Journals have not only provided a platform to share my work but have also amplified its visibility, fostering meaningful discussions and collaborations." -Analisa DiFeo, Molecular Cancer Therapeutics Author See more of what our authors are saying. buff.ly/7x8ra8e

Cancer Discovery Senior Editor I-Mei Siu, PhD, will be attending #ESMO25 and would love to hear about your research! Connect with her to discuss your work and learn about submitting to the journal.

Learn how AACR’s #openaccess, peer-reviewed journal—Cancer Research Communications—supports authors from presubmission through publication: buff.ly/NTCCGgR

Read the article in Cancer Discovery: aacrjournals.org/cancerdiscov...

From Cancer Immunology Research: buff.ly/5EfzjgB Vγ9Vδ2 T-cell infiltrates could be associated with clinical benefits in patients with TNBC. Breast tumor–infiltrating Vγ9Vδ2 T cells exhibit hallmarks of activation defects that can be reinvigorated by combining anti-BTN3A with anti–PD-1.

Read the article in Cancer Discovery: aacrjournals.org/cancerdiscov...

📢Exciting news! Cancer Discovery @aacrjournals.bsky.social is issuing another call for commentaries ahead of #AACR26! The meeting's theme is "Precision, Partnership, Purpose: Advancing Cancer Science to Save Lives Globally" - we want to hear YOUR ideas on how to achieve this goal. (1/2)

Read article collections featuring impactful, cutting-edge research on Tumor Evolution, AI and Data Science, and more: buff.ly/Oi8by86

Check out this article in Cancer Immunology Research: buff.ly/wv7ZMSG Using a CRISPR screen, the authors identify DYRK1A as a regulator of CD155 expression and show that targeting the PI3K/Akt pathway to reduce CD155 expression may help overcome resistance to PD-1 blockade in HNSCC.

Certain patients’ risk of developing #breastcancer in the future may be predicted by a genetic risk score, according to a new study from Kings College London researchers in Cancer Epidemiology, Biomarkers & Prevention. Learn more: buff.ly/Kg1yeOA

Concluding our Article Showcase is a featured selection from Melissa B. Davis, Senior Editor of Health Disparities and Outcomes Research: “Genetic Ancestry in PDXNet Models” buff.ly/jBtUKTA

A series of papers published in the AACR journal Clinical Cancer Research shared key considerations for how to improve dosage optimization in oncology. Learn more on the AACR Blog: buff.ly/ZFH90e3

Next up in our Article Showcase is a featured selection from Joya Chandra, Senior Editor of Epidemiology and Prevention: “Age and Sex Differences in the Prevalence of Specific Comorbidities among Patients with Pediatric ALL and LL at Diagnosis” buff.ly/R3Vz7BX

Up next in our Article Showcase is a featured selection from Eileen M. O’Reilly, Senior Editor of Clinical Research and Trials: “Sapanisertib plus Metformin in Metastatic Solid Tumors” buff.ly/RlwT75M

Congratulations to Editorial Board Member of Cancer Immunology Research Shimon Sakaguchi on his Nobel Prize. Read more in #CancerDiscoveryNews

Sign up to receive alerts directly to your inbox to keep up with the latest published issues: buff.ly/O6OYSDp

The next featured selection in our Article Showcase is from Jakob N. Kather, Senior Editor of Precision Medicine and Biomarkers: “Characterization of Non-Monotonic Relationships between Tumor Mutational Burden and Clinical Outcomes” buff.ly/yheXp2g @jnkt.bsky.social

Next up in our Article Showcase is a featured selection from Alex Sparreboom, Senior Editor of Therapeutic Research and Development: “Mechanistic Characterization of CAF Depletion via an ADC Targeting Fibroblast Activation Protein” buff.ly/RuStSV4

In this recent Cancer Immunology Research article, the authors show that elevated infiltration of SPP1+ TAMs is related to worse response to immunotherapy and to dysfunction of CD8+ T cells in ccRCC. The data suggest SPP1 as a potential therapeutic target in ccRCC. Read more: buff.ly/kC0UJ7y

Check out the September Editors' Picks, which are free to read for a limited time. buff.ly/iDgMhF0

Joseph C. Murray, MD, PhD, recipient of the 2025 Clinical Cancer Research Early Career Award, speaks about the questions that drive his research. To learn more, watch the full interview: buff.ly/fa085VG

Up next in our Article Showcase is a featured selection from Ankur Sharma, Senior Editor of Emerging Technologies and Data Science: “Inferring Drug–Gene Relationships in Cancer Using Literature-Augmented Large Language Models” buff.ly/GIXOuTN